Having demonstrated the clinicopathological significance of TBX5 expression in the prognosis of OS in patients with GC, additional studies are required to investigate the significance of TBX5 in patients with stage I and II GC treated with chemotherapy, and the association between TBX5 and β-catenin. Here, TBX5 is linked to gastric cancer.